Gene expression in the brain from fluoxetine-injected mouse using DNA microarray

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Fluoxetine (Prozac) is a widely used antidepressant.
• Previous research indicates fluoxetine affects nicotinic acetylcholine receptors and G protein-activated inwardly rectifying potassium (GIRK) channels.

Purpose of the Study:

• To investigate the effects of chronic fluoxetine administration on gene expression in the adult mouse brain.

Main Methods:

• Adult mice were administered fluoxetine daily for 20 days.
• RNA was extracted from the cerebral cortex of treated and control mice.
• DNA microarray analysis was employed to assess genome-wide gene expression changes.

Main Results:

• Fluoxetine treatment led to the downregulation of numerous gene expression signals in the mouse cerebral cortex.
• Specific examples of downregulated genes include cholecystokinin and prostaglandin D2 synthase.

Conclusions:

• Chronic fluoxetine exposure significantly alters gene expression patterns in the mouse brain.
• These findings suggest fluoxetine's antidepressant effects may involve modulation of specific gene pathways, including those related to cholecystokinin and prostaglandin D2 synthase.